Lineage Cell Therapeutics annual meeting: all 9 directors elected, auditor ratified, say-on-pay approved

Lineage Cell Therapeutics, Inc.

All nine director nominees elected with 89.8M-90.8M votes for and 1.5M-2.4M withheld.
Ratification of WithumSmithBrown as auditor passed: 128.6M for, 2.4M against.
Advisory say-on-pay approved: 87.8M for, 3.7M against, 0.7M abstentions.
Board amended bylaws effective June 11, 2024, updating advance notice and California code compliance.
Bylaw changes include Rule 14a-19 compliance requirement and electronic meeting provisions.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.